Relative to DMSO-only treated cells, knockdown of METAP1 or METAP2 in fluorescent pTREBAV-miR-E-transduced CRC and HCC cells depleted the knockdown cells in the population only to minor extent (mostly < 20%). The gene discussed is METAP1; the disease is hepatocellular carcinoma.